The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
HORECA, ENOEXPO 2025 – Encuentros empresariales online para el sector agroalimentario, 5-20 noviembre 2025
Encuentro empresarial organizado por la Enterprise Europe Network durante la principal feria alimentación y hostelería en Polonia (HORECA) que se combina con la industria del vino ENOEXPO. La Cámara de Comercio de Toledo junto con FEDA , en colaboración con el nodo...
Sep 29, 2025